Clinical trial
Treatment of High and Very High riSk Dyslipidemic pAtients for the PreveNTion of CardiOvasculaR Events in Europe - a MultInatioNal ObservatIonal Study (SANTORINI)
NCT04271280 is registered in ClinicalTrials.gov with Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Treatment of High and Very High riSk Dyslipidemic pAtients for the PreveNTion of CardiOvasculaR Events in Europe - a MultInatioNal ObservatIonal Study (SANTORINI)
- Lead sponsor
- Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 17, 2020
- Completion date
- April 11, 2022
- Enrollment
- 9,559 (actual)
- Sites
- 540
Conditions
As the registry lists them; a condition with its own page is linked.
atherosclerotic cardiovascular disease, cardiovascular diseases, dyslipidemia, hypercholesterolemia